BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2789155)

  • 1. Assessment of the activation pathways of the complement in psoriatic patients by use of complement fragment C4d and Bb measurements.
    Takematsu H; Tagami H
    Dermatologica; 1989; 179 Suppl 1():16-9. PubMed ID: 2789155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the alternative pathway of complement in psoriatic lesional skin.
    Takematsu H; Tagami H
    Dermatologica; 1990; 181(4):289-92. PubMed ID: 2073958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement fragment C4d and Bb levels in inflammatory skin diseases (e.g. SLE, atopic dermatitis, erythroderma and pustulosis palmaris et plantaris) for assessment of complement activation.
    Takematsu H; Tagami H
    Tohoku J Exp Med; 1991 Apr; 163(4):263-8. PubMed ID: 1831937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity.
    Manzi S; Rairie JE; Carpenter AB; Kelly RH; Jagarlapudi SP; Sereika SM; Medsger TA; Ramsey-Goldman R
    Arthritis Rheum; 1996 Jul; 39(7):1178-88. PubMed ID: 8670328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preferential activation of the alternative pathway of complement in psoriatic lesional skin.
    Takematsu H; Tagami H
    Dermatology; 1992; 184(2):159-60. PubMed ID: 1498383
    [No Abstract]   [Full Text] [Related]  

  • 6. Correlation of the activation of the fourth component of complement (C4) with disease activity in systemic lupus erythematosus.
    Senaldi G; Makinde VA; Vergani D; Isenberg DA
    Ann Rheum Dis; 1988 Nov; 47(11):913-7. PubMed ID: 3264693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical application of new technique that measures C4d for assessment of activation of classical complement pathway.
    Davies ET; Nasaruddin BA; Alhaq A; Senaldi G; Vergani D
    J Clin Pathol; 1988 Feb; 41(2):143-7. PubMed ID: 3350977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classical complement activation induced by pregnancy: implications for management of connective tissue diseases.
    Hopkinson ND; Powell RJ
    J Clin Pathol; 1992 Jan; 45(1):66-7. PubMed ID: 1740520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reflection of disease activity in rheumatoid arthritis by indices of activation of the classical complement pathway.
    Makinde VA; Senaldi G; Jawad AS; Berry H; Vergani D
    Ann Rheum Dis; 1989 Apr; 48(4):302-6. PubMed ID: 2785367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synovial fluid levels of complement SC5b-9 and fragment Bb are elevated in patients with rheumatoid arthritis.
    Brodeur JP; Ruddy S; Schwartz LB; Moxley G
    Arthritis Rheum; 1991 Dec; 34(12):1531-7. PubMed ID: 1747138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated levels of iC3b and C4d, but not Bb, complement fragments from plasma of persons infected with human T cell leukemia virus (HTLV) with HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Saarloos MN; Koenig RE; Spear GT
    J Infect Dis; 1995 Oct; 172(4):1095-7. PubMed ID: 7561187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement activation in severe Plasmodium falciparum malaria.
    Wenisch C; Spitzauer S; Florris-Linau K; Rumpold H; Vannaphan S; Parschalk B; Graninger W; Looareesuwan S
    Clin Immunol Immunopathol; 1997 Nov; 85(2):166-71. PubMed ID: 9344699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo generation of C4d, Bb, iC3b, and SC5b-9 after OKT3 administration in kidney and lung transplant recipients.
    Vallhonrat H; Williams WW; Cosimi AB; Tolkoff-Rubin N; Ginns LC; Wain JC; Preffer F; Olszak I; Wee S; Delmonico FL; Pascual M
    Transplantation; 1999 Jan; 67(2):253-8. PubMed ID: 10075589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement activation in psoriasis.
    Rosenberg EW; Noah PW; Wyatt RJ; Jones RM; Kolb WP
    Clin Exp Dermatol; 1990 Jan; 15(1):16-20. PubMed ID: 2311273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in C3, C4, factor B, and related metabolites in septic shock.
    Lin RY; Astiz ME; Saxon JC; Saha DC; Rackow EC
    Clin Immunol Immunopathol; 1993 Nov; 69(2):136-42. PubMed ID: 8403550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the complement system in human immunodeficiency virus infection: relevance of the classical pathway to pathogenesis and disease severity.
    Senaldi G; Peakman M; McManus T; Davies ET; Tee DE; Vergani D
    J Infect Dis; 1990 Dec; 162(6):1227-32. PubMed ID: 1977807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classical and alternative complement pathway activation in paracoccidioidomycosis.
    de Messias IT; Mohren D
    J Investig Allergol Clin Immunol; 1994; 4(2):91-5. PubMed ID: 7921333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement activation and immune complexes in juvenile rheumatoid arthritis.
    Jarvis JN; Pousak T; Krenz M; Iobidze M; Taylor H
    J Rheumatol; 1993 Jan; 20(1):114-7. PubMed ID: 8441140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rocket immunoelectrophoresis of C4 and C4d. A simple sensitive method for detecting complement activation in plasma.
    Nitsche JF; Tucker ES; Sugimoto S; Vaughan JH; Curd JG
    Am J Clin Pathol; 1981 Nov; 76(5):679-84. PubMed ID: 6794354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A flow cytometric assay for measuring complement receptor 1 (CR1) and the complement fragments C3d and C4d on erythrocytes.
    Freysdottir J; Sigfusson A
    J Immunol Methods; 1991 Aug; 142(1):45-52. PubMed ID: 1833467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.